Global Contraceptive Devices Market is Set to Accelerate at a CAGR of ~6% by 2032, as Demand for Advanced Birth Control Solutions Rises | DelveInsight
The global contraceptive devices market is expanding, driven by multiple influencing factors. Rising awareness and improved education around family planning are increasing adoption. Shifts in demographics and lifestyle, such as women’s empowerment and the trend toward postponing parenthood, are also strengthening demand for reliable contraceptive options. Additionally, innovations like long-acting reversible contraceptives (LARCs) and improved products with reduced side effects are appealing to a broader user base. Government-backed programs that enhance the accessibility and affordability of contraception are further accelerating market growth.
New York, USA, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Global Contraceptive Devices Market is Set to Accelerate at a CAGR of ~6% by 2032, as Demand for Advanced Birth Control Solutions Rises | DelveInsight
The global contraceptive devices market is expanding, driven by multiple influencing factors. Rising awareness and improved education around family planning are increasing adoption. Shifts in demographics and lifestyle, such as women’s empowerment and the trend toward postponing parenthood, are also strengthening demand for reliable contraceptive options. Additionally, innovations like long-acting reversible contraceptives (LARCs) and improved products with reduced side effects are appealing to a broader user base. Government-backed programs that enhance the accessibility and affordability of contraception are further accelerating market growth.
DelveInsight’s Contraceptive Devices Market Insights report provides the current and forecast market analysis, individual leading contraceptive devices companies’ market shares, challenges, contraceptive devices market drivers, barriers, trends, and key contraceptive devices companies in the market.
Contraceptive Devices Market Summary
- The global contraceptive devices market size is expected to increase from ~USD 20 billion in 2024 to ~USD 33 billion by 2032, reflecting strong and sustained growth.
- The global contraceptive devices market is expected to grow at a CAGR of ~6% during the forecast period from 2025 to 2032.
- The leading companies working in the contraceptive devices market include Reckitt Benckiser Group PLC, Church & Dwight Co., Inc., Organon & Co., Bayer AG, CooperSurgical, Inc., Mankind Pharma Ltd., HLL Lifecare Limited, Karex Berhad, Okamoto Industries Inc., Veru Inc., Pregna International Limited, Kessel medintim GmbH, and others.
- Among all the regions, North America is anticipated to register the fastest growth in the contraceptive devices market during the forecast period.
- In the product type segment of the contraceptive devices market, the condom category accounted for the largest market share in 2024.
To read more about the latest highlights related to the contraceptive devices market, get a snapshot of the key highlights entailed in the Global Contraceptive Devices Market Forecast Report
Key Factors Contributing to the Rise in Growth of the Contraceptive Devices Market
Increasing Awareness of Reproductive Health
There is a growing global emphasis on awareness about reproductive health, family planning, and the prevention of unintended pregnancies. Governments, NGOs, and healthcare providers actively promote access to contraceptive solutions as fundamental for women’s empowerment and improved maternal and child health outcomes.
Rising Demand for Family Planning Solutions
The demand for effective family planning methods is increasing globally, driven by the desire to prevent unintended pregnancies and provide women with control over their reproductive choices. This demand fuels growth in contraceptive devices like IUDs, implants, condoms, and hormonal contraceptives.
Technological Advancements and Innovation
Continuous innovation in contraceptive devices, such as the development of long-acting reversible contraceptives (LARCs), user-friendly designs, improved safety, and enhanced comfort, is attracting more users. Advances in material science and delivery mechanisms make these devices more effective, convenient, and acceptable.
Government Initiatives and Supportive Policies
Robust government promotions, public health campaigns, and favorable reimbursement policies in many regions support the adoption of contraceptive devices. These initiatives aim to reduce unplanned pregnancies and sexually transmitted infections, promoting the use of reliable contraceptive methods.
Growing Female Workforce and Societal Changes
Demographic shifts such as delayed childbirth, increasing female workforce participation, and changing societal attitudes toward family planning contribute to higher demand for convenient, long-term contraceptive options.
Increasing Prevalence of Sexually Transmitted Infections (STIs)
The rising incidence of STIs worldwide underscores the need for protective contraceptive devices, fueling demand for condoms and other barrier methods alongside hormonal and long-acting contraceptives.
Cost-Effectiveness and Convenience
Contraceptive devices are preferred for their long-term effectiveness, low maintenance, and convenience compared to other contraceptive methods. This helps boost sustained user adherence and market growth.
Get a sneak peek at the contraceptive devices market dynamics @ Contraceptive Devices Market Trends
Regional Contraceptive Devices Market Insights
North America is expected to retain its position as the leading regional market for contraceptive devices, accounting for a 41% share in 2024, equivalent to USD 9.11 billion. Growth is fueled by rising adoption of Long-Acting Reversible Contraceptives (LARCs), such as IUDs and implants, which are preferred for their high effectiveness and ease of use. Continuous technological advancements, focused on improving comfort, reducing hormone dosage, and integrating devices with digital health tools, are further supporting this shift. Demand for non-hormonal products is also increasing as consumers become more cautious about the side effects associated with hormonal methods. While the range of female contraceptive devices continues to broaden, the male segment remains heavily led by condoms due to their dual protection against pregnancy and sexually transmitted infections. Favorable healthcare policies and early-stage, yet expanding, investment in next-generation male contraceptive research and development are further shaping the regional outlook.
Europe's contraceptive devices market is growing steadily, generating around USD 5 billion in 2024 with a CAGR of approximately 5.3–5.4%. The region is seeing a strong move toward LARCs, including IUDs and implants, as users seek reliable and convenient options. Interest in non-hormonal products is also rising, driven by individuals wishing to avoid hormone-related side effects. A supportive policy environment, including subsidies and reimbursement programs in many countries, particularly for younger populations, plays a major role in market expansion. However, adoption patterns differ across the region, with Western and Northern Europe showing higher usage of advanced contraceptive methods compared to parts of Eastern and Southern Europe. Additionally, growing reliance on digital and telehealth platforms is improving access to information, prescriptions, and consultations, further driving demand.
The Asia–Pacific contraceptive devices market is expanding rapidly, with revenues projected to reach approximately USD 4.45 billion by 2024. As one of the fastest-growing regions globally, Asia–Pacific’s momentum is driven by its vast population base, accelerating urbanization, and shifting socioeconomic factors. Market trends reflect both efforts to address substantial unmet contraceptive needs and a gradual transition toward more modern and effective methods.
To know more about why North America is leading the market growth in the contraceptive devices market, get a snapshot of the Contraceptive Devices Market Share
Recent Developmental Activities in the Contraceptive Devices Market
- In May 2025, Femasys received CE Mark approval for its in-office, non-surgical permanent contraception device and delivery system, FemBloc® Permanent Birth Control System.
- In March 2025, NEXT Life Sciences announced the launch of clinical trials for Plan A, a long-lasting, reversible, and hormone-free male contraceptive. The product, which is classified as a medical device, uses an injectable hydrogel to filter out sperm for up to 10 years.
- In February 2025, FDA 510(k) clearance for Church & Dwight’s ribbed Ecstasy variant.
- In February 2025, Sebela Women's Health Inc. received FDA approval for MIUDELLA, a next-generation, hormone-free copper intrauterine system (IUS). It is the first new hormone-free IUD to be approved in the U.S. in over 40 years. It uses a flexible nitinol frame and less than half the copper of the currently available copper IUD.
- In January 2025, at Arab Health 2025, SMB Corporation unveiled the Silvee, a new silver IUD. The device features a silver core to enhance durability and effectiveness, providing up to five years of reliable contraception.
What are Contraceptive Devices?
Contraceptive devices are medical tools designed to prevent pregnancy by creating a physical or hormonal barrier that stops sperm from fertilizing an egg. They include a wide range of options such as intrauterine devices (IUDs), condoms, diaphragms, cervical caps, implants, and vaginal rings. These devices work through different mechanisms—some release hormones to inhibit ovulation or thicken cervical mucus, while others physically block sperm from reaching the uterus. Contraceptive devices offer individuals and couples safe, effective, and often reversible methods of family planning, empowering them to make informed choices about reproductive health based on their lifestyle, preferences, and long-term goals.
| Contraceptive Devices Market Report Metrics | Details |
| Coverage | Global |
| Study Period | 2022–2032 |
| Contraceptive Devices Market CAGR | ~6% |
| Contraceptive Devices Market Size by 2032 | ~USD 33 Billion |
| Key Contraceptive Devices Companies | Reckitt Benckiser Group PLC, Church & Dwight Co., Inc., Organon & Co., Bayer AG, CooperSurgical, Inc., Mankind Pharma Ltd., HLL Lifecare Limited, Karex Berhad, Okamoto Industries Inc., Veru Inc., Pregna International Limited, Kessel medintim GmbH, and others |
Contraceptive Devices Market Assessment
-
Contraceptive Devices Market Segmentation
- Contraceptive Devices Market Segmentation By Product Type: Condom, Diaphragms, Cervical Cap, Vaginal Rings, Intrauterine Device (IUD), and Sub Dermal Contraceptive Implants
- Contraceptive Devices Market Segmentation By Gender: Male Contraceptive Devices, Female Contraceptive Devices
- Contraceptive Devices Market Segmentation By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacies and D2C Platforms, Hypermarkets and Supermarkets, and Others
- Contraceptive Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the contraceptive devices market are set to emerge as the trendsetter explore @ Contraceptive Devices Market Analysis
Table of Contents
| 1 | Contraceptive Devices Market Report Introduction |
| 2 | Contraceptive Devices Market Executive Summary |
| 3 | Competitive Landscape |
| 4 | Regulatory Analysis |
| 5 | Contraceptive Devices Market Key Factors Analysis |
| 6 | Contraceptive Devices Market Porter’s Five Forces Analysis |
| 7 | Contraceptive Devices Market Layout |
| 8 | Contraceptive Devices Market Company and Product Profiles |
| 9 | KOL Views |
| 10 | Project Approach |
| 11 | About DelveInsight |
| 12 | Disclaimer & Contact Us |
Interested in knowing the contraceptive devices market share by 2032? Click to get a snapshot of the Contraceptive Devices Market Size
Related Reports
Contraceptive Drugs Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key contraceptive drugs companies, including Pfizer Inc., Abbvie Inc., BAYER AG, Gedeon Richter Plc., Mayne Pharma, Merck & Co., Inc., Teva Pharmaceuticals, Novartis AG, Johnson & Johnson, Sanofi, Cipla Ltd., Zydus Cadila, Torrent Pharmaceuticals Ltd., Mankind Pharma, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Aurobindo Pharma Limited, Amneal Pharmaceuticals LLC., Maxwellia Ltd., Theramex, among others.
Contraceptives Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key contraceptives companies, including Teva Pharmaceutical Industries Ltd, TherapeuticsMD, Inc., AbbVie Inc., Bayer AG, The Cooper Companies Inc., FemCap Inc, Veru Inc., Meril Life Sciences Pvt. Ltd., Pregna International Limited., Reckitt Benckiser Group PLC., Viatris Inc., EUROGINE, S.L, Gedeon Richter Plc., Agile Therapeutics., Evofem Biosciences, Inc., Amneal Pharmaceuticals LLC., Shanghai Dahua Pharmaceutical Co., Ltd., Pfizer Inc., Contech Devices Private Limited, Cupid Limited, among others.
Intrauterine Devices Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key intrauterine devices companies, including CooperSurgical Inc, Bayer AG, Odyssea Pharma SPRL, Merck & Co Inc, Allergan Inc, EUROGINE S.L, OCON Medical Ltd, HLL Lifecare Limited, Mona Lisa, Prosan International BV, SMB Corporation of India, Medicines360, AbbVie Inc, Teva Pharmaceutical Industries Ltd, Pregna International Limited, HRA Pharma, Melbea Innovations, Mylan N.V, Meril Life Sciences Pvt. Ltd, among others.
Medicated Intrauterine Devices Market
Medicated Intrauterine Devices Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key medicated intrauterine devices companies, including Bayer, Agile Therapeutics, Actavis PLC, Allergan, Pregna International Limited, among others.
Condom Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key condom companies, including Reckitt Benckiser Group PLC., HUMANWELL, Karex Berhad., Okamoto Industries, Inc., Church & Dwight, Mayer Laboratories, Inc., Mankind Pharma, Veru Inc., Cupid Limited, FUJILATEX CO., LTD, Caution Wear Corp., ONE Condoms, Sagami Rubber Industries Co., Ltd., THAI NIPPON RUBBER INDUSTRY PUBLIC COMPANY LIMITED., TTK Healthcare, Unique Condoms, AdvaCare Pharma, RITEX GMBH, Asha International, LELO iAB, GLYDE Health Pty. Ltd., among others.
DelveInsight’s Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.
Other Business Pharmaceutical Consulting Services
Healthcare Conference Coverage
Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us Shruti Thakur info@delveinsight.com +14699457679
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
